Testosterone alters duodenal calcium transport and longitudinal bone growth rate in parallel in the male rat.
Duodenal active calcium transport and longitudinal bone growth rate have been shown previously to be regulated in parallel by alteration of gonadal hormone status in sexually maturing female rats. The present study was designed to extend these observations to the sexually maturing male rat. Male rats were orchidectomized (ORX) and given Silastic implants containing either testosterone or estradiol at 6 weeks of age. At 9 weeks of age, duodenal active calcium transport was measured by the everted gut sac method and longitudinal bone growth rate was determined by tetracycline labeling. Decreases in body weight, longitudinal bone growth rate, duodenal calcium transport, and serum Ca and P were exhibited by ORX animals as compared with age-matched control animals. Testosterone administration to ORX animals resulted in an increase in body weight, longitudinal bone growth rate, duodenal calcium transport, and serum Ca and P as compared with ORX animals to a level not significantly different from that of age-matched control animals. Estradiol administration to ORX animals resulted in an additional decrease in body weight, although no significant effect on duodenal calcium transport, serum Ca, or P was noted as compared with ORX animals. There were no statistically significant alterations in the circulating levels of 1,25-dihydroxyvitamin D, parathyroid hormone, or osteocalcin in response to any of the experimental manipulations of gonadal status. These results indicate that, as in the female, gonadal hormone status affects intestinal calcium transport in sexually maturing male rats in parallel with changes in bone growth rate by mechanisms that are independent of circulating levels of 1,25-dihydroxyvitamin D.
Hope
W G
WG
Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston 77550.
Ibarra
M J
MJ
Thomas
M L
ML
D000818:Animals; D001693:Biological Transport, Active / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D001846:Bone Development / Q000187:drug effects*; D002117:Calcitriol / Q000097:blood; D002118:Calcium / Q000097:blood / Q000378:metabolism*; D004343:Drug Implants; D004386:Duodenum / Q000187:drug effects / Q000378:metabolism*; D006133:Growth Substances / Q000097:blood; D066298:In Vitro Techniques; D007335:Insulin-Like Growth Factor II; D007413:Intestinal Mucosa / Q000187:drug effects / Q000378:metabolism; D008297:Male; D009919:Orchiectomy; D009929:Organ Size / Q000187:drug effects; D010281:Parathyroid Hormone / Q000097:blood; D010710:Phosphates / Q000097:blood; D011506:Proteins / Q000378:metabolism; D051381:Rats; D012016:Reference Values; D013739:Testosterone / Q000008:administration & dosage / Q000494:pharmacology*
D004343:Drug Implants; D006133:Growth Substances; C035170:IGF2 protein, human; D010281:Parathyroid Hormone; D010710:Phosphates; D011506:Proteins; D013739:Testosterone; D007335:Insulin-Like Growth Factor II; D002117:Calcitriol; D002118:Calcium